Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2024-09-18 00:00:00 ET · period of report 2024-07-18 · accession 0001628280-24-040834 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-18 | 2024-07-18+ | BLFS | Foster Karen A. | Chief Quality, Ops | S - Sale | $24.16 | -603 | 157.6K | -0.4% | -$14.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-21 | S | D | 96 | $25.61 | 157,835 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-18 | S | D | 240 | $22.50 | 157,931 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-16 | S | D | 267 | $25.12 | 157,568 | D | — | — |